1 Liu Q,Song J,Pan Y,et al.Wnt5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression[J].Int J Biol Sci,2020,16(6):1023-1034. 2 Chow A,Zhou W,Liu L,et al.Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-kappaB[J].Sci Rep,2014,4:5750. 3 Rhee I.Diverse macrophages polarization in tumor microenvironment[J].Arch Pharm Res,2016,39(11):1588-1596. 4 Han Q,Zhao H,Jiang Y,et al.HCC-Derived exosomes:critical player and target for cancer immune escape[J].Cells,2019,8(6):558. 5 Zhang X,Shi H,Yuan X,et al.Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration[J].Mol Cancer,2018,17(1):146. 6 Kowalski LP,Sanabria A.Elective neck dissection in oral carcinoma:a critical review of the evidence[J].Acta Otorhinolaryngol Ital,2007,27(3):113-117. 7 Cai J,Qiao B,Gao N,et al.Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p[J].Am J Physiol Cell Physiol,2019,316(5):731-740. 8 Pang X,Wang SS,Zhang M,et al.OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway[J].Cancer Immunol Immunother,2021,70(4):1015-1029. 9 Lan B,Zeng S,Grutzmann R,et al.The role of exosomes in pancreatic cancer[J].Int J Mol Sci,2019,20(18):4332. 10 Wang X,Luo G,Zhang K,et al.Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kgamma to promote pancreatic cancer metastasis[J].Cancer Res,2018,78(16):4586-4598. 11 Linton SS,Abraham T,Liao J,et al.Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages[J].PLoS One,2018,13(11):e206759. 12 Li X,Lei Y,Wu M,et al.Regulation of macrophage activation and polarization by HCC-derived exosomal lncRNA TUC339[J].Int J Mol Sci,2018,19(10):2958. 13 Wu J,Li H,Xie H,et al.The malignant role of exosomes in the communication among colorectal cancer cell,macrophage and microbiome[J].Carcinogenesis,2019,40(5):601-610. 14 Wang D,Wang X,Si M,et al.Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J].Cancer Lett,2020,474:36-52. 15 Takano Y,Masuda T,Iinuma H,et al.Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer[J].Oncotarget,2017,8(45):78598-78613. 16 Liang ZX,Liu HS,Wang FW,et al.LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J].Cell Death Dis,2019,10(11):829. 17 Zhao S,Mi Y,Guan B,et al.Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer[J].J Hematol Oncol,2020,13(1):156. 18 Chen X,Ying X,Wang X,et al.Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization[J].Oncol Rep,2017,38(1):522-528. 19 Ying X,Wu Q,Wu X,et al.Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages[J].Oncotarget,2016,7(28):43076-43087. 20 Chen X,Zhou J,Li X,et al.Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype[J].Cancer Lett,2018,435:80-91. 21 Kumari N,Saxena S,Agrawal U.Exosomal protein interactors as emerging therapeutic targets in urothelial bladder cancer[J].J Egypt Natl Canc Inst,2015,27(2):51-58. 22 Elsharkawi F,Elsabah M,Shabayek M,et al.Urine and serum exosomes as novel biomarkers in detection of bladder cancer[J].Asian Pac J Cancer Prev,2019,20(7):2219-2224. 23 Lin F,Yin HB,Li XY,et al.Bladder cancer cellsecreted exosomal miR21 activates the PI3K/AKT pathway in macrophages to promote cancer progression[J].Int J Oncol,2020,56(1):151-164. 24 Aldawsari HM,Gorain B,Alhakamy NA,et al.Role of therapeutic agents on repolarisation of tumour-associated macrophage to halt lung cancer progression[J].J Drug Target,2020,28(2):166-175. 25 Chen L,Yang Y,Huang C,et al.Human THP-1 macrophages activated by exosomes derived from lung adenocarcinoma cells promote lung cancer cell invasion][J].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2019,35(11):967-972. 26 Hsu YL,Hung JY,Chang WA,et al.Hypoxic lung-cancer-derived extracellular vesicle MicroRNA-103a increases the oncogenic effects of macrophages by targeting PTEN[J].Mol Ther,2018,26(2):568-581. 27 Pritchard A,Tousif S,Wang Y,et al.Lung tumor cell-derived exosomes promote M2 macrophage polarization[J].Cells,2020,9(5):1303. 28 Yang L,Zhang Y.Tumor-associated macrophages:from basic research to clinical application[J].J Hematol Oncol,2017,10(1):58. 29 Ham S,Lima LG,Chai E,et al.Breast cancer-derived exosomes alter macrophage polarization via gp130/STAT3 signaling[J].Front Immunol,2018,9:871. 30 Piao YJ,Kim HS,Hwang EH,et al.Breast cancer cell-derived exosomes and macrophage polarization are associated with lymph node metastasis[J].Oncotarget,2018,9(7):7398-7410. 31 Gowda R,Robertson BM,Iyer S,et al.The role of exosomes in metastasis and progression of melanoma[J].Cancer Treat Rev,2020,85:101975. 32 Bardi GT,Smith MA,Hood JL.Melanoma exosomes promote mixed M1 and M2 macrophage polarization[J].Cytokine,2018,105:63-72. 33 Gerloff D,Lutzkendorf J,Moritz R,et al.Melanoma-derived exosomal miR-125b-5p educates tumor associated macrophages(TAMs)by targeting lysosomal acid lipase A(LIPA)[J].Cancers(Basel),2020,12(2):464. 34 Lapointe S,Perry A,Butowski NA.Primary brain tumours in adults[J].Lancet,2018,392(10145):432-446. 35 Whiteside TL.Immune modulation of T-cell and NK(natural killer)cell activities by TEXs(tumour-derived exosomes)[J].Biochem Soc Trans,2013,41(1):245-251. 36 Li Z,Bao S,Wu Q,et al.Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells[J].Cancer Cell,2009,15(6):501-513. 37 Qian M,Wang S,Guo X,et al.Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-kappaB pathways[J].Oncogene,2020,39(2):428-442. |